Archive: Raymond J. March
San Francisco’s Vaping Ban Is Doomed To Go Up in Smoke
Government efforts to regulate away vices can also motivate more dangerous or unhealthy behaviors.
Right-to-Try Legislation Helps Patient Battling Bone Cancer
After receiving access to experimental treatments, Natalie’s condition improved substantially.
FDA Approves Ketamine-Based Drug to Treat Difficult Cases of Depression
Although much work remains to reverse the DEA’s overzealous scheduling system, Ketamine-based treatment for mental illness is another step in the right direction.
Healthcare Needs Price Competition, Not Just Transparency
Efforts to make healthcare costs more transparent are a good start. But transparency is no substitute for competition.
Competition is the Key to Reducing Insulin Prices
Not More Government Involvement
Right-to-Try’s First Rescue
A Patient with Terminal Brain Cancer Gets Treatment
If Teen Vaping Is Bad, the Alternative Is Worse
The FDA’s efforts to reduce teen vaping rates will likely result in worse health outcomes by prompting teens to switch to smoking cigarettes.
Evaporating Vaping Options
The FDA Moves to Regulate Away Consumer Choices
The FDA Loosens the Rules on Saving Lives
A Good Step, but Much More is Needed
Telemedicine Is Popular: Why Isn’t It Everywhere?
Will telemedicine revolutionize the healthcare industry?
Medical Apps: Improving Healthcare on a Global Scale
Around 70% of all health problems can be handled online.
Right-to-Try Is Just What the Doctor Ordered
Right-to-Try opens new doors for terminally ill patients.